High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function

A young patient develops cerebral posttransplant lymphoproliferative disorder. Despite concurrent significantly impaired transplant kidney function use of add-on high-flux hemodialysis for additional clearance made the administration of high-dose methotrexate feasible in this patient without occuren...

Descripción completa

Detalles Bibliográficos
Autores principales: Reshetnik, Alexander, Scheurig-Muenkler, Christian, van der Giet, Markus, Tölle, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641477/
https://www.ncbi.nlm.nih.gov/pubmed/26576275
http://dx.doi.org/10.1002/ccr3.302
_version_ 1782400210551439360
author Reshetnik, Alexander
Scheurig-Muenkler, Christian
van der Giet, Markus
Tölle, Markus
author_facet Reshetnik, Alexander
Scheurig-Muenkler, Christian
van der Giet, Markus
Tölle, Markus
author_sort Reshetnik, Alexander
collection PubMed
description A young patient develops cerebral posttransplant lymphoproliferative disorder. Despite concurrent significantly impaired transplant kidney function use of add-on high-flux hemodialysis for additional clearance made the administration of high-dose methotrexate feasible in this patient without occurence of acute chronic kidney failure and significant hematological toxicity.
format Online
Article
Text
id pubmed-4641477
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-46414772015-11-16 High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function Reshetnik, Alexander Scheurig-Muenkler, Christian van der Giet, Markus Tölle, Markus Clin Case Rep Case Reports A young patient develops cerebral posttransplant lymphoproliferative disorder. Despite concurrent significantly impaired transplant kidney function use of add-on high-flux hemodialysis for additional clearance made the administration of high-dose methotrexate feasible in this patient without occurence of acute chronic kidney failure and significant hematological toxicity. John Wiley & Sons, Ltd 2015-11 2015-09-25 /pmc/articles/PMC4641477/ /pubmed/26576275 http://dx.doi.org/10.1002/ccr3.302 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Reshetnik, Alexander
Scheurig-Muenkler, Christian
van der Giet, Markus
Tölle, Markus
High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
title High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
title_full High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
title_fullStr High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
title_full_unstemmed High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
title_short High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
title_sort high-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641477/
https://www.ncbi.nlm.nih.gov/pubmed/26576275
http://dx.doi.org/10.1002/ccr3.302
work_keys_str_mv AT reshetnikalexander highfluxhemodialysisafteradministeringhighdosemethotrexateinapatientwithposttransplantlymphoproliferativediseaseandimpairedrenalfunction
AT scheurigmuenklerchristian highfluxhemodialysisafteradministeringhighdosemethotrexateinapatientwithposttransplantlymphoproliferativediseaseandimpairedrenalfunction
AT vandergietmarkus highfluxhemodialysisafteradministeringhighdosemethotrexateinapatientwithposttransplantlymphoproliferativediseaseandimpairedrenalfunction
AT tollemarkus highfluxhemodialysisafteradministeringhighdosemethotrexateinapatientwithposttransplantlymphoproliferativediseaseandimpairedrenalfunction

Ejemplares similares